AHA comments on the Health Resources and Services Administration’s (HRSA) information collection request (ICR) regarding the expected costs of its 340B Rebate Model Pilot Program.

Rural hospitals and community health centers are lifelines to the communities they serve. They keep small towns healthy and well, both physically and economically. In New Hampshire alone, hospitals ...

Spending through the 340B Drug Pricing Program rose by 565% between 2010 and 2021, increasing from $6.6 billion to $43.9 billion, according to a report from the Congressional Budget Office. In 2021, ...

Disappointed, but not surprised. That was my reaction to the news that two more pharmaceutical groups are suing the state of North Dakota over a new law designed to protect the 340B Drug Pricing ...

On Wednesday, health care providers and drug manufacturers hotly debated legislation looking to ensure hospitals can purchase ...

The White House has proposed good and bad ideas to reduce drug costs. Among the better ones is a reform of the obscure 340B ...

New York state lawmakers are considering a bill that'd make it easier for big hospital systems to siphon off financial aid that's meant for poor patients. The bill involves the 340B Drug Pricing ...

A group of House lawmakers is urging HHS to scrap or revise its proposed 340B rebate model pilot program, warning the model could dismantle the original intent of the program and harm safety-net ...

The country’s largest hospital lobby is accusing five major drugmakers of secretly conspiring to transition to a rebate model in 340B, in the latest salvo between providers and pharmaceutical ...